75.44
-0.45 (-0.59%)
-0.45 (-0.59%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Merck and Co Inc | MRK | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.45 | -0.59% | 75.44 | 20:00:00 |
| Close Price | Low Price | High Price | Open Price | Previous Close |
|---|---|---|---|---|
| 75.21 | 73.94 | 75.89 | 75.34 | 75.89 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 93,994 | 10,589,124 | $ 74.94 | $ 793,547,714 | 8,243,651 | 65.25 - 92.64 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:58:38 | 10 | $ 75.22 | USD |
Merck Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 190.81B | 2.53B | 2.53B | $ 46.84B | $ 11.42B | 3.81 | 19.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 10.98M | $ 2.26 | 3.00% | - | - |
Merck News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRK Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 79.37 | 80.62 | 73.94 | 77.68 | 8,962,709 | -3.93 | -4.95% |
| 1 Month | 80.72 | 82.63 | 73.94 | 79.20 | 8,369,589 | -5.28 | -6.54% |
| 3 Months | 80.70 | 87.80 | 73.94 | 82.44 | 8,046,821 | -5.26 | -6.52% |
| 6 Months | 79.82 | 87.80 | 73.572 | 80.05 | 8,887,037 | -4.38 | -5.49% |
| 1 Year | 85.04 | 92.64 | 65.25 | 81.10 | 10,088,614 | -9.60 | -11.29% |
| 3 Years | 55.75 | 92.64 | 52.83 | 73.64 | 10,266,677 | 19.69 | 35.32% |
| 5 Years | 55.04 | 92.64 | 47.97 | 68.59 | 9,616,610 | 20.40 | 37.06% |
Merck Description
| Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to 40% of the firm's sales are generated in the United States. |
